Smolen J.S., Aletaha D., Bijlsma J.W., Breedveld F.C., Boumpas D., Burmester G. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631–637. https://doi.org/10.1136/ard.2009.123919..
DOI: 10.1136/ard.2009.123919
Smolen J.S., Schöls M., Braun J., Dougados M., Fitzgerald J., Gladman D.D. et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77(1):3–17. https://doi.org/10.1136/annrheumdis-2017-211734..
DOI: 10.1136/annrheumdis-2017-211734
Fanouriakis F., Kostopoulou M., Alunno A., Aringer M., Bajema I., Boletis J.N. et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745. https://doi.org/10.1136/annrheumdis-2019-215089..
DOI: 10.1136/annrheumdis-2019-215089
Насонов Е.Л. (ред.). Ревматология: Российские клинические рекомендации. М.: ГЭОТАР-Медиа; 2020, с. 169-181.
Yates M., Watts R.A., Bajema I.M., Cid M.C., Crestani B., Hauser T. et al. EULAR/ERA-EDTA recommendations for the management of ANCAassociated vasculitis. Ann Rheum Dis. 2016;75(9):1583–1594. https://doi.org/10.1136/annrheumdis-2016-209133..
DOI: 10.1136/annrheumdis-2016-209133
Hellmich B., Agueda A., Monti S., Butgereit F., de Boysson H., Brouwer E. et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19–30. https://doi.org/10.1136/annrheumdis-2019-215672..
DOI: 10.1136/annrheumdis-2019-215672
Dejaco C/, Singh Y.P., Perel P., Hutchings A., Camellino D., Mackie S. et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74(10): 1799–1807. https://doi.org/10.1136/annrheumdis-2015-207492..
DOI: 10.1136/annrheumdis-2015-207492
Smolen J.S., Landewe R.B. M., Bijlsma J.W. J., Burmester G.R., Dougados M., Kerschbaumer A. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. https://doi.org/10.1136/annrheumdis-2019-216655..
DOI: 10.1136/annrheumdis-2019-216655
Fraenkel L., Bathon J.M., England B.R., St Clair E.W., Arayssi T., Carandang K. et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research. 2021;73(7):924–939. https://doi.org/10.1002/acr.24596..
DOI: 10.1002/acr.24596
van der Heijde D., Ramiro S., Landewe R., Baraliakos X., Van der Bosch F., Sepriano A. et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770..
DOI: 10.1136/annrheumdis-2016-210770
Singh J.A., Guyatt G., Ogdie A., Gladman D.D., Deal C., Deodhar A. et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019;71(1):5–32. https://doi.org/10.1002/art.40726..
DOI: 10.1002/art.40726
Gossec L., Baraliakos X., Kerschbaumer A., de Wit M., McInnes I., Dougados M. et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79(6):700–712. https://doi.org/10.1136/annrheumdis-2020-217159..
DOI: 10.1136/annrheumdis-2020-217159
Hollander J.L., Brown E.M. Jr., Jessar R.A., Brown C.Y. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc. 1951;147(17):1629–1635. https://doi.org/10.1001/jama.1951.03670340019005..
DOI: 10.1001/jama.1951.03670340019005
Hollander J.L., Jessar R.A., Brown E.M. Jr. Intra-synovial corticosteroid therapy: a decade of use. Bull Rheum Dis. 1961;11:239–240. Available at: https://pubmed.ncbi.nlm.nih.gov/13715306.https://pubmed.ncbi.nlm.nih.gov/13715306
Hollander J.L., Jessar R.A., Brown E.M. Jr. Intra-synovial corticosteroid therapy: a decade of use. Bull Rheum Dis. 1961;11:239–240. Available at: https://pubmed.ncbi.nlm.nih.gov/13715306.https://pubmed.ncbi.nlm.nih.gov/13715306
Uson J., Rodriguez-Garsia S.C., Castellanos-Moreira R., O’Neill T.W., Doherty M., Boesen M. et.al. EULAR recommendations for intra-articular therapies. Ann Rheum Dis. 2021;80(10):1299–1305. https://doi.org/10.1136/annrheumdis-2021-220266..
DOI: 10.1136/annrheumdis-2021-220266
Насонов Е.Л., Чичасова Н.В., Ковалев В.Ю. Локальная терапия глюкокортикоидами. РМЖ. 1999;(8):7. Режим доступа: https://rmj.ru/articles/revmatologiya/LOKALYNAYa_TERAPIYa_GLYuKOKORTIKOIDAMI.https://rmj.ru/articles/revmatologiya/LOKALYNAYa_TERAPIYa_GLYuKOKORTIKOIDAMI
Насонов Е.Л., Чичасова Н.В., Ковалев В.Ю. Локальная терапия глюкокортикоидами. РМЖ. 1999;(8):7. Режим доступа: https://rmj.ru/articles/revmatologiya/LOKALYNAYa_TERAPIYa_GLYuKOKORTIKOIDAMI.https://rmj.ru/articles/revmatologiya/LOKALYNAYa_TERAPIYa_GLYuKOKORTIKOIDAMI
Насонов Е.Л., Чичасова Н.В., Ковалев В.Ю. Глюкокортикоиды в ревматологии. М.; 1998. 160 с.
van der Goes M.C., Straub R.H., Wenting M.J., Capellino S., Jacobs J.W., Jahangier Z.N. et al. Intra-articular glucocorticoid injections decrease the number of steroid hormone receptor positive cells in synovial tissue of patients with persistent knee arthritis. Ann Rheum Dis. 2012;71(9):1552–1558. https://doi.org/10.1136/annrheumdis-2011-201019..
DOI: 10.1136/annrheumdis-2011-201019
Horton D.B., Haynes K., Denburg M.R., Thacker M.M., Rose C.D., Putt M.E. et al. Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study. BMJ Open. 2017;7(7):e016788. https://doi.org/10.1136/bmjopen-2017-016788..
DOI: 10.1136/bmjopen-2017-016788
Weitoft T., Rönnelid J., Knight A., Lysholm J., Saxne T., Larsson A. Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis – a prospective cohort study. Arthritis Res Ther. 2014;16(3):R129. https://doi.org/10.1186/ar4586..
DOI: 10.1186/ar4586
Maricar N., Callaghan M.J., Felson D.T., O’Neill T.W. Predictors of response to intra-articular steroid injections in knee osteoarthritis--a systematic review. Rheumatology (Oxford). 2013;52(6):1022–1032. https://doi.org/10.1093/rheumatology/kes368..
DOI: 10.1093/rheumatology/kes368
Godwin M., Dawes M. Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician. 2004;50:241–248. Available at: https://pubmed.ncbi.nlm.nih.gov/15000335.https://pubmed.ncbi.nlm.nih.gov/15000335
Godwin M., Dawes M. Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician. 2004;50:241–248. Available at: https://pubmed.ncbi.nlm.nih.gov/15000335.https://pubmed.ncbi.nlm.nih.gov/15000335
Skwara A., Ponelis R., Tibesku C.O., Rosenbaum D., Fuchs-Winkelmann S. Gait patterns after intraarticular treatment of patients with osteoarthritis of the knee--hyaluronan versus triamcinolone: a prospective, randomized, doubleblind, monocentric study. Eur J Med Res. 2009;14(4):157–164. https://doi.org/10.1186/2047-783X-14-4-157..
DOI: 10.1186/2047-783X-14-4-157
Navarrete Álvarez J.M., Coronel Granado P., García Jiménez O.A., Gimeno Del Sol M., Gil Orbezo F. Clinical efficacy of intra-articular injections in knee osteoarthritis: a prospective randomized study comparing hyaluronic acid and betamethasone. Open Access Rheumatol. 2015;7:9–18. https://doi.org/10.2147/OARRR.S74553..
DOI: 10.2147/OARRR.S74553
Hetland M.L., Østergaard M., Ejbjerg B., Jacobsen S., StengaardPedersen K., Junker P. et al. Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP. Ann Rheum Dis. 2012;71(6):851–856. https://doi.org/10.1136/annrheumdis-2011-200632..
DOI: 10.1136/annrheumdis-2011-200632
Zhang W., Doherty M., Bardin T., Pascual T., Barskova V., Conaghan P. et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1312–1324. https://doi.org/10.1136/ard.2006.055269..
DOI: 10.1136/ard.2006.055269
Habib G., Khazin F., Sakas F., Hakim G., Artul S. The impact of intraarticular injection of diprospan at the knee joint on blood glucose levels in diabetic patients. Eur J Rheumatol. 2018;5(2):96–99. https://doi.org/10.5152/eurjrheum.2018.17133..
DOI: 10.5152/eurjrheum.2018.17133
Cheng J., Abdi S. Complications of joint, tendon, and muscle injections. Tech Reg Anesth Pain Manag. 2007;11(3):141–147. https://doi.org/10.1053/j.trap.2007.05.006..
DOI: 10.1053/j.trap.2007.05.006
Habib G.S., Saliba W., Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol. 2010;29(4):347–356. https://doi.org/10.1007/s10067-009-1357-y..
DOI: 10.1007/s10067-009-1357-y
Rozental T.D., Sculco T.P. Intra-articular corticosteroids: an updated overview. Am J Orthop (Belle Mead NJ). 2000;29(1):18–23. Available at: https://pubmed.ncbi.nlm.nih.gov/10647515.https://pubmed.ncbi.nlm.nih.gov/10647515
Rozental T.D., Sculco T.P. Intra-articular corticosteroids: an updated overview. Am J Orthop (Belle Mead NJ). 2000;29(1):18–23. Available at: https://pubmed.ncbi.nlm.nih.gov/10647515.https://pubmed.ncbi.nlm.nih.gov/10647515
Cole B.J., Schumacher H.R. Jr. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg. 2005;13(1):37–46. https://doi.org/10.5435/00124635-200501000-00006..
DOI: 10.5435/00124635-200501000-00006
Cheng O.T., Souzdalnitski D., Vrooman B., Cheng J. Evidence-based knee injections for the management of arthritis. Pain Med. 2012;13(6):740–753. https://doi.org/10.1111/j.1526-4637.2012.01394.x..
DOI: 10.1111/j.1526-4637.2012.01394.x
Hunter J.A., Blyth T.H. A risk-benefit assessment of intra-articular corticosteroids in rheumatic disorders. Drug Saf. 1999;21(5):353–365. https://doi.org/10.2165/00002018-199921050-00002..
DOI: 10.2165/00002018-199921050-00002
Laroche M., Arlet J., Mazieres B. Osteonecrosis of the femoral and humeral heads after intraarticular corticosteroid injections. J Rheumatol. 1990;17(4):549–551. https://pubmed.ncbi.nlm.nih.gov/2348435https://pubmed.ncbi.nlm.nih.gov/2348435
Laroche M., Arlet J., Mazieres B. Osteonecrosis of the femoral and humeral heads after intraarticular corticosteroid injections. J Rheumatol. 1990;17(4):549–551. https://pubmed.ncbi.nlm.nih.gov/2348435https://pubmed.ncbi.nlm.nih.gov/2348435